News

Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.

Rice, MD Anderson develop program to ID mutations in single cancer cells.

Company has announced that Toray has approved it as provider of expression profiling services on their “3D Gene” microarray platform.

Discovery of mutations paves the way for personalised treatment of breast cancer.

Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.

Research into the impact of a child’s upbringing and social and physical environments on the development of asthma will receive $2 million to tackle the condition that affects as many as one in three Canadians.

Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.

Group sales of €629.1 million (18.5% growth in sales).

Penn Institute for Biomedical Informatics and colleagues identify "roadmap" of disease mechanisms to identify candidate drug targets.

They’re the top questions on everyone’s mind when a new disease outbreak happens: where did the virus come from? When did this happen? How long has it been spreading in a particular country or group of people?